Dr Reddy Launches Anti-Cancer Injection in US

3172624911_e089f10034_oDr. Reddy’s Laboratories Ltd, a pharmaceutical company based in Hyderabad, Telangana, India recently launched DOCETAXEL Injection USP 20 mg/ml and 80 mg/ 4ml a generic version of TAXOTERE in the US market. The market value of the drug is worth $218 billion in the US Market.

Taxotere (docetaxel) is a cancer medication that interferes with the growth and spread of cancer cells in the body.

Dr Reddy’s Docetaxel injection USP 20 mg/mL and 80 mg/4 mL are available as a single dose, one vial formulation that does not require a prior dilution with a diluent and is ready to add to the intravenous infusion solution.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s